Diane Mathis

Diane Mathis is currently the Morton Grove-Rasmussen Professor of Immunohematology at Harvard Medical School, principal faculty member at the Harvard Stem Cell Institute and associate faculty member of the Broad Institute. Her lab focuses on the fields of T cell differentiation, autoimmunity and inflammation. Throughout her career, Diane has trained more than 175 students and postdoctoral fellows.

Previously, Diane was a professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, and associate research director and head of the section on immunology and immunogenetics at Joslin Diabetes Center through 2008.

Diane currently serves on the advisory boards of Rockefeller University, the Howard Hughes Medical Institute, Genentech, Pfizer, Amgen and several research institutes worldwide. She was elected to the U.S. National Academy of Sciences in 2003, the German Academy in 2007 and the American Academy of Arts and Sciences in 2012. In 2016, Diane received the FASEB Excellence in Science Award.

Diane holds a Ph.D. from the University of Rochester and performed postdoctoral studies at the Laboratoire de Génétique Moléculaire des Eucaryotes in Strasbourg, France and at Stanford University Medical Center. She returned to Strasbourg at the end of 1983, establishing a laboratory at the LGME (later the Institut de Genetique et de Biologie Moleculare et Cellulaire) in conjunction with Dr. Christophe Benoist. The lab moved to the Joslin Diabetes Center in Boston in 1999.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Abata Therapeutics

1 followers

Abata Therapeutics is bringing an entirely new approach to the treatment of autoimmune disease by engineering Tregs as targeted therapies that stop immune-mediated destruction, restore homeostasis – a state of harmony – and promote repair in the affected tissues. In addition to their lead program in progressive MS, Abata has early programs in Type 1 Diabetes (T1D) and inclusion body myositis (IBM). They bring together industry experts and deeply engaged pioneers in Treg biology, T cell receptor and antigen discovery, disease pathogenesis, and molecular and imaging biomarkers.


Industries

Employees

11-50

Links